MedTrace Logo

Managing Insulin With a Voice AI

NCT05081011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-01-02

Study results available
· View outcomes & findings →

Summary

This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

Conditions

  • Medication Adherence

Interventions

DEVICE

Voice Assistant Device

Voice AI-enabled smart speaker device delivers daily custom insulin titration instructions.

DEVICE

Voice Assistant Device

Voice AI-enabled smart speaker device delivers daily generic insulin reminders.

Sponsors & Collaborators

Principal Investigators

  • Kevin Schulman, MD, MBA · Stanford University

  • Ashwin Nayak, MD · Stanford University

  • Sharif Vakili, MD, MS, MBA · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-24
Primary Completion
2022-12-01
Completion
2022-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05081011 on ClinicalTrials.gov